Subtype
Pancreatic Carcinoma
CI-CAN-00003562Explore in graph →
488 active trials5 approved drugs31 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003562Explore in graph →
Clinical trials
1,381 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (201)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00397787 | Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00363051 | Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy | completed | Phase 2 | 160 | Novartis PharmaceuticalsINDUSTRY | 11 | May 10, 2013 | clinicaltrials |
| NCT00296114 | Pancreatic Cancer Serum and DNA Repository | completed | — | 690 | Pancreatic Cancer Research TeamOTHER | 2 | May 1, 2013 | clinicaltrials |
| NCT00680420 | DNA Microarray Study of Pancreas Cancer | completed | — | 27 | Oregon Health and Science UniversityOTHER | 1 | Mar 7, 2013 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT01401387 | Pancreatic Enzyme Suppletion in Pancreatic Cancer(EPC) | withdrawn | Phase 4 | 0 | Foundation for Liver ResearchOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00028496 | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00028834 | Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00039403 | UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT01774162 | EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration | completed | N/A | 57 | University of AlbertaOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00075647 | CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT01278368 | Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic Resection | completed | N/A | 150 | Università Vita-Salute San RaffaeleOTHER | 1 | Dec 24, 2012 | clinicaltrials |
| NCT00480584 | A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer | completed | Phase 1 | 20 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 8, 2012 | clinicaltrials |
| NCT00660205 | Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer(GIVTE) | completed | — | 285 | University of AarhusOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT01543412 | Second Line Chemotherapy for Advanced Pancreatic Cancer(SLAP) | completed | Phase 2 | 50 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Mar 5, 2012 | clinicaltrials |
| NCT00913198 | A Study of CP-4126 in Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 21 | Clavis PharmaINDUSTRY | 2 | Feb 10, 2012 | clinicaltrials |
| NCT00593008 | Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer | terminated | Phase 1 | 5 | Massachusetts General HospitalOTHER | 1 | Dec 2, 2011 | clinicaltrials |
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer(CORGI) | completed | Phase 1 / Phase 2 | 106 | Lund University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00500968 | Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail | completed | N/A | 50 | Karolinska InstitutetOTHER | 1 | Apr 7, 2011 | clinicaltrials |
| NCT01330823 | L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)(CARPAN) | suspended | Phase 3 | 72 | University Medicine GreifswaldOTHER | 1 | Apr 7, 2011 | clinicaltrials |
| NCT00428597 | A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors | terminated | Phase 3 | 171 | PfizerINDUSTRY | 11 | Oct 11, 2010 | clinicaltrials |
| NCT00873353 | Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients(XELTA) | completed | Phase 2 | 32 | Grupo Gallego de Investigaciones OncologicasOTHER | 1 | Aug 18, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00947102 | Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer(GEMSTHER) | unknown | — | — | Blood Transfusion Centre of SloveniaOTHER_GOV | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00137761 | Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 52 | Massachusetts General HospitalOTHER | 0 | Aug 10, 2009 | clinicaltrials |
| NCT00644254 | The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma(ECLNI DPAC) | completed | — | 145 | KU LeuvenOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00259532 | Three New Methods for Diagnosing Pancreas Cancer | unknown | N/A | 80 | University of CopenhagenOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00585845 | Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment | terminated | Phase 1 | 17 | Anza Therapeutics, Inc.INDUSTRY | 2 | Feb 20, 2009 | clinicaltrials |
| NCT00637364 | High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain(HIFU Pancreas) | suspended | Phase 1 / Phase 2 | 5 | CMED HIFU Development CorporationINDUSTRY | 1 | Jan 13, 2009 | clinicaltrials |
| NCT00809081 | Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy | unknown | Phase 3 | 38 | Yonsei UniversityOTHER | 1 | Dec 16, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Jun 4, 2013source: clinicaltrials